Participate in a Study
Seattle Cancer Care Alliance (SCCA) was formed, in part, to bring promising new treatments to patients faster. For lung cancer patients, this means more treatment options at SCCA than they might find elsewhere, including the chance to participate in one of many ongoing clinical studies conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
Not all patients are cured with standard therapy, and some standard treatments may have more side effects than are desired. So patients may seek help through a clinical study. Patients who participate in these studies, also called clinical trials, have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease.
- For more information about clinical studies, see the Patient Guide to Clinical Trials, which includes myths and facts.
- You can also see information about specific lung cancer clinical studies that are currently open and accepting patients at SCCA. For patients with advanced lung cancer, be sure to check the current roster of open Phase 1 trials.